Zebra Capital Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-12,466
Closed -$46K 160
2021
Q4
$46K Sell
12,466
-4,596
-27% -$19.8K 0.07% 152
2021
Q3
$85K Sell
17,062
-386
-2% -$2.22K 0.1% 177
2021
Q2
$114K Sell
17,448
-1,884
-10% -$13.2K 0.13% 150
2021
Q1
$133K Buy
+19,332
New +$163K 0.15% 156

Other funds holding PGEN

Zebra Capital Management's PGEN Position: Q1 2022 in Review

Zebra Capital Management sold out of Precigen (PGEN) in Q1 2022, closing a stake of 12,466 shares — an estimated $46K sold.

Zebra Capital Management first reported a position in PGEN in Q1 2021 and held it in 4 quarters. The position peaked at $133K in Q1 2021. 173 funds tracked by Wall St. Rank hold PGEN as of Q1 2022.

  • Zebra Capital Management reported no remaining Precigen position as of Q1 2022 after selling out during the quarter.
  • Zebra Capital Management sold 12,466 Precigen shares in Q1 2022, an estimated $46K.
  • Zebra Capital Management first reported a position in Precigen in Q1 2021 and held it in 4 quarters.
  • Zebra Capital Management's Precigen position peaked at $133K in Q1 2021.
  • 173 funds tracked by Wall St. Rank held Precigen as of Q1 2022.

Based on Zebra Capital Management's 13F filing for Q1 2022, filed 16 May 2022.